Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Alliance A051301/BMT-CTN 1201 Study - Ibrutinib + Standard Conditioning and as Consolidation After AutoHCT for R/R ABC-DLBCL"
Login to view comments.
Click here to Login